Related Experiment Videos

PEGylated interferon plus ribavirin in chronic hepatitis C

¹St. Louis University School of Medicine, 3635 Vista Avenue at Grand Boulevard, PO Box 15250, St. Louis, MO 63110-0250, USA.

Current Gastroenterology Reports

|February 15, 2001

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Real-world effectiveness for 12 weeks of ledipasvir-sofosbuvir for genotype 1 hepatitis C: the Trio Health study.

Journal of viral hepatitis·2016

Disparate access to treatment regimens in chronic hepatitis C patients: data from the TRIO network.

Journal of viral hepatitis·2016

Adherence to assigned dosing regimen and sustained virological response among chronic hepatitis C genotype 1 patients treated with boceprevir plus peginterferon alfa-2b/ribavirin.

Alimentary pharmacology & therapeutics·2013

Meta-analysis: re-treatment of genotype I hepatitis C nonresponders and relapsers after failing interferon and ribavirin combination therapy.

Alimentary pharmacology & therapeutics·2010

Clinical trial: randomized controlled study of zidovudine and lamivudine for patients with primary biliary cirrhosis stabilized on ursodiol.

Alimentary pharmacology & therapeutics·2008

Iron absorption and hepatic iron uptake are increased in a transferrin receptor 2 (Y245X) mutant mouse model of hemochromatosis type 3.

American journal of physiology. Gastrointestinal and liver physiology·2006

See all related articles